Literature DB >> 15362227

The talin-tail interaction places integrin activation on FERM ground.

Iain D Campbell1, Mark H Ginsberg.   

Abstract

Integrins are essential receptors for the development and functioning of multicellular animals because they mediate cell migration and cell adhesion, and regulate cell proliferation and apoptosis. Cellular regulation of the affinity of integrins for ligands - so-called 'integrin activation' - is a central property of these receptors. Integrin activation controls cell adhesion, migration and extracellular matrix assembly, thereby contributing to processes such as angiogenesis, tumor cell metastasis, inflammation, the immune response and hemostasis. Recent studies indicate that a crucial, final step in integrin activation is the binding of talin, a cytoskeletal protein, to the cytoplasmic domain of the integrin beta subunit. These results provide a focus for unraveling the many biochemical pathways implicated in integrin activation and suggest a general structural model for the connections between integrins and diverse cellular signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15362227     DOI: 10.1016/j.tibs.2004.06.005

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  38 in total

1.  Focal Adhesion Induction at the Tip of a Functionalized Nanoelectrode.

Authors:  Daniela E Fuentes; Chilman Bae; Peter J Butler
Journal:  Cell Mol Bioeng       Date:  2011-12       Impact factor: 2.321

Review 2.  Cell adhesion: integrating cytoskeletal dynamics and cellular tension.

Authors:  J Thomas Parsons; Alan Rick Horwitz; Martin A Schwartz
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09       Impact factor: 94.444

3.  Spatial coordination of kindlin-2 with talin head domain in interaction with integrin β cytoplasmic tails.

Authors:  Kamila Bledzka; Jianmin Liu; Zhen Xu; H Dhanuja Perera; Satya P Yadav; Katarzyna Bialkowska; Jun Qin; Yan-Qing Ma; Edward F Plow
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

4.  The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation.

Authors:  Brian G Petrich; Per Fogelstrand; Anthony W Partridge; Nima Yousefi; Ararat J Ablooglu; Sanford J Shattil; Mark H Ginsberg
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

5.  WAVE2 regulates high-affinity integrin binding by recruiting vinculin and talin to the immunological synapse.

Authors:  Jeffrey C Nolz; Ricardo B Medeiros; Jason S Mitchell; Peimin Zhu; Bruce D Freedman; Yoji Shimizu; Daniel D Billadeau
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

Review 6.  Focal adhesion: a focal point in current cell biology and molecular medicine.

Authors:  Chuanyue Wu
Journal:  Cell Adh Migr       Date:  2007-01-27       Impact factor: 3.405

7.  The structure of an integrin/talin complex reveals the basis of inside-out signal transduction.

Authors:  Nicholas J Anthis; Kate L Wegener; Feng Ye; Chungho Kim; Benjamin T Goult; Edward D Lowe; Ioannis Vakonakis; Neil Bate; David R Critchley; Mark H Ginsberg; Iain D Campbell
Journal:  EMBO J       Date:  2009-10-01       Impact factor: 11.598

8.  Beta integrin tyrosine phosphorylation is a conserved mechanism for regulating talin-induced integrin activation.

Authors:  Nicholas J Anthis; Jacob R Haling; Camilla L Oxley; Massimiliano Memo; Kate L Wegener; Chinten J Lim; Mark H Ginsberg; Iain D Campbell
Journal:  J Biol Chem       Date:  2009-10-20       Impact factor: 5.157

9.  Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation.

Authors:  Lena Svensson; Kimberley Howarth; Alison McDowall; Irene Patzak; Rachel Evans; Siegfried Ussar; Markus Moser; Ayse Metin; Mike Fried; Ian Tomlinson; Nancy Hogg
Journal:  Nat Med       Date:  2009-02-22       Impact factor: 53.440

Review 10.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.